{"id":269481,"date":"2026-09-25T09:31:22","date_gmt":"2026-09-25T04:01:22","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=269481"},"modified":"2026-09-25T09:31:22","modified_gmt":"2026-09-25T04:01:22","slug":"epigral-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/epigral-best-stock-in-its-sector\/","title":{"rendered":"Is Epigral the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"

Epigral CMP Rs 1,061 (25 Sep 2026). Market cap Rs 4,624 Cr. ROE 14.94%. P\/E 17.06x versus Industry P\/E 37.32x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Epigral is one of the names investors compare when screening the Chemicals sector, built on a 14.94% return on equity and a P\/E of 17.06x against an Industry P\/E of 37.32x. Whether Epigral is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Chemicals sector peers, so you can judge that for yourself.<\/p>\n<\/p><\/div>\n

Is Epigral<\/a> the best stock in its sector? The stock trades on the NSE at Rs 1,061 as of 25 September 2026, within its 52-week range of Rs 807.00 to Rs 1,771.00. Epigral Ltd, formerly Meghmani Finechem, manufactures chloromethanes and other specialty chemicals.<\/p>\n

Epigral sits in the Chemicals sector, and its 14.94% ROE and 17.06x P\/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P\/E benchmark.<\/p>\n

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n